Laboratory biomarkers associated with COVID-19 severity and management

The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi-organ failure and death. Identification of high-risk cases will enable appropriate intervention and escalation. This study inv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical immunology (Orlando, Fla.) Fla.), 2020-12, Vol.221, p.108614-108614, Article 108614
Hauptverfasser:	Keddie, S., Ziff, O., Chou, M.K.L., Taylor, R.L., Heslegrave, A., Garr, E., Lakdawala, N., Church, A., Ludwig, D., Manson, J., Scully, M., Nastouli, E., Chapman, M.D., Hart, M., Lunn, M.P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biomarkers Biomarkers - blood C-Reactive Protein - metabolism COVID-19 COVID-19 - blood COVID-19 - diagnosis COVID-19 - therapy COVID-19 - virology CRP Cytokine Release Syndrome - blood Cytokine Release Syndrome - diagnosis Cytokine Release Syndrome - therapy Cytokine Release Syndrome - virology Cytokines Female Full Length Hospitalization Humans IL-10 IL-6 Intensive care Interleukin-10 - blood Interleukin-6 - blood L-Lactate Dehydrogenase - blood LDH Male Middle Aged Respiration, Artificial Respiratory Distress Syndrome - blood Respiratory Distress Syndrome - diagnosis Respiratory Distress Syndrome - therapy Respiratory Distress Syndrome - virology Risk Factors SARS-CoV-2 - pathogenicity Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!